Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin-augmented CBT for Loneliness
NCT04137432Phase 1Unknown
- Sponsor
- University Hospital Bonn
- Start
- Sep 2019
- Primary completion
- Sep 2020
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of oxytocin nasal spray in loneliness (2 arms), sponsored by University Hospital Bonn. Primary endpoints: UCLA Loneliness Scale, State loneliness and 9 more. Status: unknown.
02
Drugs
oxytocin nasal spray
03
Conditions
loneliness
Beyond the preview
Go deeper on NCT04137432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04137432.